Bausch Health Companies (BHC) Other Operating Expenses (2009 - 2026)
Bausch Health Companies (BHC) posted Other Operating Expenses of -$26.0 million for Q2 2026, up 18.75% sequentially from -$32.0 million in Q1 2026, and down 244.44% YoY from $18.0 million in Q2 2025.
Bausch Health Companies (BHC) Other Operating Expenses (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Other Operating Expenses for 18 years, with the latest figure at -$26.0 million in Q2 2026.
- Quarterly Other Operating Expenses fell 244.44% year-over-year to -$26.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$203.0 million (up 9.38% YoY) and the FY2025 annual result came in at -$142.0 million, up 42.51% from the prior year.
- Other Operating Expenses rose to -$26.0 million in Q2 2026 per BHC's latest filing, from -$32.0 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $83.0 million in Q2 2023 and troughed at -$225.0 million in Q3 2024.
- A 5-year average of -$31.9 million and a median of -$24.5 million in 2023 frame the typical range for Other Operating Expenses.
- The widest YoY moves for Other Operating Expenses: up 190.0% in 2025, down 3150.0% in 2025.
- Over 5 years, Other Operating Expenses stood at -$29.0 million in 2022, then grew by 3.45% to -$28.0 million in 2023, then surged by 92.86% to -$2.0 million in 2024, then plunged by 3150.0% to -$65.0 million in 2025, then soared by 60.0% to -$26.0 million in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered -$26.0 million, -$32.0 million, and -$65.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Bausch Health Companies | 2.58 Bn | 738.25 Mn | 2.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -26.00 Mn |
| Mar 31, 2026 | -32.00 Mn |
| Dec 31, 2025 | -65.00 Mn |
| Sep 30, 2025 | -80.00 Mn |
| Jun 30, 2025 | 18.00 Mn |
| Mar 31, 2025 | -15.00 Mn |
| Dec 31, 2024 | -2.00 Mn |
| Sep 30, 2024 | -225.00 Mn |
| Jun 30, 2024 | -20.00 Mn |
| Dec 31, 2023 | -28.00 Mn |
| Sep 30, 2023 | -60.00 Mn |
| Jun 30, 2023 | 83.00 Mn |
| Mar 31, 2023 | -23.00 Mn |
| Dec 31, 2022 | -29.00 Mn |
| Sep 30, 2022 | -4.00 Mn |
| Mar 31, 2022 | -2.00 Mn |
| Dec 31, 2021 | -44.00 Mn |
| Sep 30, 2021 | 183.00 Mn |
| Jun 30, 2021 | -542.00 Mn |
| Mar 31, 2021 | 30.00 Mn |